SUBSCRIBE
SUBSCRIBE
News   Deals

Belgian Ablynx Plans IPO this Year

October 10, 2007 | 
1 min read
BRUSSELS/LONDON, Oct 10 (Reuters) - Belgium's Ablynx, which is using llamas to develop a new class of drugs, plans to raise funds through an initial public offering on Euronext Brussels this year, it said on Wednesday.
IPO Europe
MORE ON THIS TOPIC
AbbVie's office in South San Francisco, California
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.
Gene therapy
AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M
July 9, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Big fish with dollar sign eating many small ones. Competition, merger, business, monopoly concept. EPS 8 vector illustration, no transparency
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
July 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
July 8, 2025
 · 
1 min read
 · 
Annalee Armstrong